Atea Pharmaceuticals Inc
NASDAQ:AVIR
Atea Pharmaceuticals Inc
NASDAQ:AVIR
Price:
6.1
USD
Market Closed
Market Cap:
$476.6m
Cash Flow Statement
Cash Flow Statement
Atea Pharmaceuticals Inc
Atea Pharmaceuticals Inc
Currency: USD
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||
| Net Income |
(14)
|
(16)
|
(22)
|
(36)
|
(11)
|
24
|
35
|
25
|
121
|
48
|
16
|
36
|
(116)
|
(109)
|
(106)
|
(131)
|
(136)
|
(164)
|
(176)
|
(174)
|
(168)
|
(139)
|
(136)
|
(147)
|
(158)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
5
|
7
|
15
|
24
|
31
|
40
|
44
|
46
|
46
|
47
|
48
|
48
|
49
|
49
|
49
|
50
|
50
|
52
|
46
|
38
|
30
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
5
|
8
|
15
|
24
|
31
|
40
|
44
|
46
|
44
|
41
|
39
|
36
|
35
|
34
|
34
|
35
|
36
|
40
|
36
|
30
|
24
|
16
|
|
| Change in Working Capital |
1
|
1
|
2
|
6
|
300
|
246
|
215
|
251
|
(248)
|
(222)
|
(193)
|
(255)
|
(47)
|
(22)
|
(19)
|
11
|
16
|
34
|
19
|
11
|
(7)
|
(23)
|
(11)
|
(11)
|
16
|
|
| Cash from Operating Activities |
(13)
N/A
|
(14)
-9%
|
(20)
-42%
|
(26)
-29%
|
297
N/A
|
284
-4%
|
275
-3%
|
307
+12%
|
(87)
N/A
|
(129)
-49%
|
(131)
-1%
|
(175)
-33%
|
(121)
+31%
|
(92)
+24%
|
(89)
+3%
|
(85)
+4%
|
(85)
0%
|
(95)
-12%
|
(121)
-27%
|
(127)
-5%
|
(135)
-7%
|
(126)
+7%
|
(117)
+7%
|
(134)
-15%
|
(132)
+2%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(487)
|
(454)
|
(429)
|
(383)
|
46
|
40
|
73
|
150
|
87
|
56
|
85
|
(24)
|
139
|
189
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(2)
N/A
|
(489)
-25 632%
|
(455)
+7%
|
(431)
+5%
|
(383)
+11%
|
46
N/A
|
40
-12%
|
73
+81%
|
150
+106%
|
87
-42%
|
56
-36%
|
85
+51%
|
(24)
N/A
|
139
N/A
|
189
+36%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
107
|
107
|
532
|
532
|
426
|
426
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(14)
|
(25)
|
(25)
|
|
| Other |
0
|
0
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
106
N/A
|
106
-1%
|
532
+404%
|
532
+0%
|
426
-20%
|
428
+0%
|
2
-100%
|
1
-20%
|
1
N/A
|
1
-50%
|
0
-33%
|
0
N/A
|
0
N/A
|
0
-25%
|
0
-14%
|
0
-19%
|
0
N/A
|
0
+8%
|
0
+19%
|
(0)
N/A
|
(14)
-6 127%
|
(26)
-80%
|
(26)
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||||
| Net Change in Cash |
(13)
N/A
|
(14)
-9%
|
87
N/A
|
80
-8%
|
828
+938%
|
817
-1%
|
701
-14%
|
734
+5%
|
(86)
N/A
|
(128)
-50%
|
(132)
-3%
|
(663)
-403%
|
(576)
+13%
|
(522)
+9%
|
(471)
+10%
|
(39)
+92%
|
(45)
-15%
|
(22)
+50%
|
29
N/A
|
(39)
N/A
|
(79)
-101%
|
(42)
+47%
|
(155)
-273%
|
(21)
+86%
|
31
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||||||
| Free Cash Flow |
(13)
N/A
|
(14)
-9%
|
(20)
-42%
|
(26)
-29%
|
297
N/A
|
284
-4%
|
275
-3%
|
307
+12%
|
(87)
N/A
|
(129)
-49%
|
(133)
-3%
|
(177)
-33%
|
(123)
+30%
|
(94)
+24%
|
(89)
+5%
|
(85)
+4%
|
(85)
0%
|
(95)
-12%
|
(121)
-27%
|
(127)
-5%
|
(135)
-7%
|
(126)
+7%
|
(117)
+7%
|
(134)
-15%
|
(132)
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
